Hstm.O
Healthstream Inc (HSTM.O) provides application software solutions, primarily within the health care technology sector, generating revenue through software licensing and related services.
Business. Healthstream Inc (HSTM.O) provides application software solutions, primarily within the health care technology sector, generating revenue through software licensing and related services.
Analyst recommendations
5 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
1Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Peers
- EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated · ServiceNow (NOW)
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Healthstream Inc (HSTM.O) provides application software solutions, primarily within the health care technology sector, generating revenue through software licensing and related services.
Healthstream maintains a conservative capital structure with zero debt, resulting in a debt-to-equity ratio of 0.0. The balance sheet shows total assets of $520.4 million against total equity of $354.0 million, providing a solid equity base. Liquidity is supported by $36.2 million in cash and equivalents, while operating cash flow stands at $63.3 million, significantly exceeding capital expenditures of $3.7 million. This strong free cash flow generation supports the company's low liquidity risk assessment.
Profitability metrics indicate modest returns on capital, with a return on equity of 5.63% and a return on assets of 3.83%. The company generated $18.3 million in net income on $304.1 million in revenue, yielding a net margin of approximately 6.0%. Operating income was $20.2 million, suggesting efficient cost management relative to revenue generation. Without cohort median data for direct comparison, these returns appear stable but not exceptional for a software entity, reflecting the capital-light nature of the business model.
Revenue concentration details by segment or geography are not provided in the available data, preventing a detailed analysis of exposure risks. The company operates within the Health Care Technology industry, which typically involves long-term contracts with healthcare providers, implying stable but potentially slow-moving revenue streams. The absence of segment data limits the ability to assess diversification benefits or specific growth drivers within the portfolio.
Growth trajectory analysis is constrained by the absence of historical period data in the input. The current revenue base of $304.1 million provides a snapshot of scale, but year-over-year trends cannot be calculated from the provided financial snapshot alone. The company's position in the software sector suggests potential for recurring revenue models, but specific growth rates remain undisclosed in this analysis.
Risk assessment indicates low liquidity risk and low dilution risk, with no immediate filing-based flags detected. The share count remains stable with 29.6 million basic and diluted shares outstanding, indicating no recent significant equity issuance or buyback activity. The primary risks appear to be operational and market-related rather than financial or structural, given the strong balance sheet and cash position.
Recent observations include analyst estimates with a mean price target of $33.50, implying upside from the current market price of $28.85. The mean recommendation of 2.40 suggests a moderate buy sentiment among analysts, with one strong buy, one buy, and three hold ratings. News events reflect internal reconciler activities rather than external corporate actions, indicating no major recent disclosures or market-moving events.
- Debt-free balance sheet with $36.2M cash provides strong financial flexibility.
- Modest returns (ROE 5.6%, ROA 3.8%) reflect stable but not high-growth profitability.
- Analyst consensus suggests upside potential with a mean target of $33.50 vs $28.85 price.
- Low dilution and liquidity risks indicate a stable capital structure.
- Lack of historical data limits growth trend analysis.
Bull / Bear case
analysis pipelineIn focus — financials by report
Revenue $81.2M, +10,5% YoY; Operating income +71,6% YoY.
- ▍Revenue $81.2M, +10,5% YoY
- ▍Operating income +71,6% YoY
- ▍Net income +36,4% YoY
- ▍Free cash flow +65,7% YoY
- ▍Net margin 7.3%
Revenue $79.7M, +7,4% YoY; Operating income −48,7% YoY.
- ▍Revenue $79.7M, +7,4% YoY
- ▍Operating income −48,7% YoY
- ▍Net income −48,2% YoY
- ▍Free cash flow −23,3% YoY
- ▍Net margin 3.2%
Revenue $76.5M, +4,6% YoY; Operating income +16,4% YoY.
- ▍Revenue $76.5M, +4,6% YoY
- ▍Operating income +16,4% YoY
- ▍Net income +6,3% YoY
- ▍Free cash flow +4,4% YoY
- ▍Net margin 8.0%
Revenue $74.4M, +4,0% YoY; Operating income +33,4% YoY.
- ▍Revenue $74.4M, +4,0% YoY
- ▍Operating income +33,4% YoY
- ▍Net income +29,3% YoY
- ▍Free cash flow −10,0% YoY
- ▍Net margin 7.2%
Revenue $73.5M; Operating income $4.4M.
- ▍Revenue $73.5M
- ▍Operating income $4.4M
- ▍Net margin 5.9%
Revenue $74.2M; Operating income $4.7M.
- ▍Revenue $74.2M
- ▍Operating income $4.7M
- ▍Net margin 6.6%
Revenue $73.1M; Operating income $6.5M.
- ▍Revenue $73.1M
- ▍Operating income $6.5M
- ▍Net margin 7.8%
Revenue $71.6M; Operating income $4.4M.
- ▍Revenue $71.6M
- ▍Operating income $4.4M
- ▍Net margin 5.8%
Revenue $304.1M, +4,3% YoY; Operating income −4,9% YoY.
- ▍Revenue $304.1M, +4,3% YoY
- ▍Operating income −4,9% YoY
- ▍Net income −8,3% YoY
- ▍Free cash flow −12,8% YoY
- ▍Net margin 6.0%
Revenue $291.6M, +4,5% YoY; Operating income +32,9% YoY.
- ▍Revenue $291.6M, +4,5% YoY
- ▍Operating income +32,9% YoY
- ▍Net income +31,5% YoY
- ▍Free cash flow +17,9% YoY
- ▍Net margin 6.9%
Revenue $279.1M, +4,6% YoY; Operating income +28,7% YoY.
- ▍Revenue $279.1M, +4,6% YoY
- ▍Operating income +28,7% YoY
- ▍Net income +25,8% YoY
- ▍Free cash flow +1,3% YoY
- ▍Net margin 5.5%
Revenue $266.8M, +3,9% YoY; Operating income +54,5% YoY.
- ▍Revenue $266.8M, +3,9% YoY
- ▍Operating income +54,5% YoY
- ▍Net income +106,9% YoY
- ▍Free cash flow +44,2% YoY
- ▍Net margin 4.5%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,75 |
| Revenue | —no estimate | —no estimate | 327,3M USD |
| Operating income | —no estimate | —no estimate | 27,0M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 249exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
- Director · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
- Director · Restricted Share Units → Common StockAcquired 3 654grant · 2026-05-28
- Director · Restricted Share Units → Common StockAcquired 3 654grant · 2026-05-28
- Director · Restricted Share Units → Common StockAcquired 3 654grant · 2026-05-28
Actions
Ask Handelsavisen
- Reference data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Market Capmarket_price * shares_outstanding_diluted
- HEALTHSTREAM INC Market data — financials · 2026-07-29
- reconciler_enqueue (reconciler) on HSTM.O · 2026-07-29
- HealthStream Inc Market data — analyst estimates · 2026-07-29
- HealthStream Inc Market data — ESG · 2026-07-29
- HSTM.O HA canonical relationships · 2026-07-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,01 %$30M
- Investment Managers · as of 2026-03-310,00 %$8M
- Investment Managers · as of 2024-06-300,00 %$112M
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2024-12-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$7M
- Investment Managers · as of 2026-03-310,00 %$15M
- Institutional Investor · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2025-12-310,00 %$59M
- Investment Managers · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$21M
- Funds · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$8M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Leadership
- Robert A. FristChairman of the Board, Chief Executive Officer
Insider activity
- Director · Common Stock HoldingSold 6 000 @ $29,00$174K · 2026-07-06
- Director · Common Stock HoldingOther 1 249 · 2026-06-08
- Director · Common Stock HoldingOther 3 148 · 2026-06-08
- Director · Common Stock HoldingOther 3 148 · 2026-06-08
- Director · Common Stock HoldingOther 3 148 · 2026-06-08
- Director · Common Stock HoldingOther 3 148 · 2026-06-08
- Director · Common Stock HoldingOther 3 148 · 2026-06-08
- Director · Common Stock HoldingOther 3 148 · 2026-06-08
- Director · Common Stock HoldingOther 3 148 · 2026-06-08
- Director · Common Stock HoldingSold 2 000 @ $25,00$50K · 2026-06-01
- Director · Common Stock HoldingSold 2 000 @ $25,00$50K · 2026-05-28
- Director · Common Stock HoldingOther 1 482 @ $24,63$37K · 2026-05-28
- Executive Vice President · Common Stock HoldingSold 3 000 @ $24,08$72K · 2026-05-20
- Executive Vice President · Common Stock HoldingOther 1 774 @ $21,25$38K · 2026-03-30
- CFO and SVP · Common Stock HoldingOther 5 601 · 2026-03-30
- CFO and SVP · Common Stock HoldingOther 1 364 @ $21,25$29K · 2026-03-30
- Executive Vice President · Common Stock HoldingOther 1 382 @ $21,25$29K · 2026-03-30
- Executive Vice President · Common Stock HoldingOther 5 672 · 2026-03-30
- Executive Vice President · Common Stock HoldingOther 5 672 · 2026-03-30
- Executive Vice President · Common Stock HoldingOther 1 382 @ $21,25$29K · 2026-03-30
- Executive Vice President · Common Stock HoldingOther 7 285 · 2026-03-30
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Cash & equivalents (annual): USD 36.16MUnknown
- Shares outstanding (annual): 29.58MUnknown
- Total assets (annual): USD 520.37MUnknown
- Current assets (annual): USD 119.66MUnknown
- Revenue (annual): USD 304.06MUnknown
- Current liabilities (annual): USD 124.15MUnknown
- Operating income (annual): USD 20.24MUnknown
- Shareholders' equity (annual): USD 354.02MUnknown
- Pre-tax income (annual): USD 23.22MUnknown
- EPS (diluted) (annual): USD-PER-SHARES 1Unknown
- Net income (annual): USD 18.34MUnknown
- Capex (annual): USD 3.69MUnknown
- EPS (basic) (annual): USD-PER-SHARES 1Unknown
- Operating cash flow (annual): USD 63.32MUnknown
- R&D expense (annual): USD 50.98MUnknown
- Shareholders' equity (annual): USD 359.36MUnknown
- Operating cash flow (annual): USD 57.66MUnknown
- Capex (annual): USD 1.4MUnknown
- Current assets (annual): USD 153.12MUnknown
- Total assets (annual): USD 510.77MUnknown
- Shares outstanding (annual): 30.43MUnknown
- Cash & equivalents (annual): USD 59.47MUnknown
- R&D expense (annual): USD 48.89MUnknown
- Revenue (annual): USD 291.65MUnknown